Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-011839

Chief Executive Officer sold 8,009 shares at $209.85 ($1,680,699)

  • Chief Executive Officer acquired 8,009 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-07 Exercise or conversion : show line 1 in the form 10b5-1 +8,009 $101.64 $814,035 463,482 D
2025-04-07 Sale : show line 2 in the form 10b5-1 −8,009 $209.85 $1,680,699 455,472 D
Open-market sales · 8,009 sh · avg $209.85 · $1,680,699

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-07 Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options −8,009 56,065 D
Loading xslF345X05/form4.xml…